Literature DB >> 36269441

Successful treatment with repeated dexamethasone implant injections for recurrent macular edema after acute retinal necrosis.

Ragnhild Øvstebø Sørland1, Anne Kjersti Erichsen2, Thora Elisabet Jonsdottir2, Marius Nordberg Bromnes2, Peter Mæhre Lauritzen3, Jon Roger Eidet2.   

Abstract

BACKGROUND: The treatment of recurrent cystoid macular edema associated with acute retinal necrosis is challenging due to the concern that treatment with intravitreal steroids may reactivate the retinitis. CASE REPORT: An immunocompetent patient diagnosed with acute retinal necrosis was treated with oral valacyclovir and intravitreal injections of foscarnet. Giant tears in her retina necessitated a vitrectomy with silicone oil. She developed cystoid macular edema after the removal of the silicone oil. The edema responded to high-dose prednisolone but recurred when the dose was tapered to 20 mg daily. Under close surveillance and increased antiviral medication, she was treated with a dexamethasone implant with complete resolution of the edema. Unfortunately, the edema recurred, and the treatment had to be repeated. Over 18 months, she received five dexamethasone implants without recurrence of the viral retinitis.
CONCLUSIONS: This case shows successful treatment of recurring cystoid macular edema following acute retinal necrosis with repeated intravitreal dexamethasone implants in a patient receiving valacyclovir maintenance treatment.
© 2022. The Author(s).

Entities:  

Keywords:  Acute retinal necrosis; Cystoid macular edema; Dexamethasone implant; Valacyclovir

Year:  2022        PMID: 36269441      PMCID: PMC9587196          DOI: 10.1186/s12348-022-00310-5

Source DB:  PubMed          Journal:  J Ophthalmic Inflamm Infect        ISSN: 1869-5760


  11 in total

Review 1.  Emerging concepts in the management of acute retinal necrosis.

Authors:  Robert William Wong; J Michael Jumper; H Richard McDonald; Robert N Johnson; Arthur Fu; Brandon J Lujan; Emmett T Cunningham
Journal:  Br J Ophthalmol       Date:  2012-12-12       Impact factor: 4.638

Review 2.  Bilateral central retinal artery occlusion associated with herpes simplex virus-associated acute retinal necrosis and meningitis: case report and literature review.

Authors:  Heather M Weissman; Valerie Biousse; Marcos Coutinho Schechter; Carlos Del Rio; Steven Yeh
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-02       Impact factor: 1.300

3.  Causes and frequency of blindness in patients with intraocular inflammatory disease.

Authors:  A Rothova; M S Suttorp-van Schulten; W Frits Treffers; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

4.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

5.  Recurrent varicella-zoster virus retinitis in a patient treated with systemic corticosteroids.

Authors:  N Satoh; T Abe; A Nakajima; S Sakuragi
Journal:  Ocul Immunol Inflamm       Date:  1998-09       Impact factor: 3.070

6.  Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.

Authors:  Friederike Mackensen; Carsten Heinz; Matthias D Becker; Arnd Heiligenhaus
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

7.  Aflibercept in the management of acute retinal necrosis syndrome-related macular edema.

Authors:  Leticia Ortega-Evangelio; Javier Navarrete-Sanchis; Basil K Williams; Juan Miguel Tomás-Torrent
Journal:  Eur J Ophthalmol       Date:  2017-09-14       Impact factor: 2.597

8.  Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis.

Authors:  Parthopratim Dutta Majumder; Jyotirmay Biswas; Asra Ambreen; Rowayda Amin; Zahedur Rahman Pannu; Ahmed Magdy Bedda
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-12-23

Review 9.  Update in treatment of uveitic macular edema.

Authors:  Spyridon Koronis; Panagiotis Stavrakas; Miltiadis Balidis; Nikolaos Kozeis; Paris G Tranos
Journal:  Drug Des Devel Ther       Date:  2019-02-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.